
"I'm watching shares of Kenview actually falling close to a record low or closing at a record low, down seven and a half percent today... formerly the consumer health care division of Johnson & Johnson."
Kenvue, the spun-off consumer healthcare company from Johnson & Johnson, is under pressure as its shares are nearing record lows, declining by 7.5%. The drop comes amid controversy over a proposed link between Tylenol's active ingredient and autism, signaling potential risks for investors.
Closing Bell: Nvidia Rallies, Oracle Soars, Kenvue Drops
September 22, 2025
Company Opinion